Osso VR, a San Francisco, CA-based validated virtual reality (VR) surgical training and assessment platform, secured $66m in Series C funding.
The round was led by Oak HC/FT with participation from Signalfire, GSR Ventures, Tiger Global Management and Kaiser Permanente Ventures.
The company intends to use the capital to accelerate initiatives to broaden access to surgical education for all healthcare professionals and continue the investment in hiring talent to bring surgical training experiences to additional specialty areas.
Led by Justin Barad, MD, CEO and Co-Founder, Osso VR produces on-demand, immersive modules that allow surgical teams to train independently or collaboratively in a virtual environment before ever stepping foot into a real operating room. Medical device companies also use Osso VR to introduce technology digitally, addressing many challenges of traditional educational pathways such as conflicting physician schedules, remote staff, and costly travel. With Osso VR, more surgeons can practice utilizing complex medical technologies to more rapidly offer their patients access to the best procedures with optimal outcomes.
Osso VR currently partners with global medical device companies, including Johnson & Johnson, Stryker, Zimmer Biomet, and Smith + Nephew. The company’s modules cover multiple specialty areas, such as orthopedics, spine, interventional cardiology, and general surgery, amongst others.
Osso VR has more than 150 employees.
FinSMEs
24/03/2022